Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0000950170-24-006198

Chief Operating Officer sold 5,000 shares at $48.00 ($240,000)

  • Chief Operating Officer acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Goldshleger Ilya Chief Operating Officer 2024-01-22 Option exercise 10b5-1 +5,000 $18.90 $94,500 31,475 D
Goldshleger Ilya Chief Operating Officer 2024-01-22 Sale 10b5-1 −5,000 $48.00 $240,000 26,475 D
Derivatives
Goldshleger Ilya Chief Operating Officer 2024-01-22 Option exercise · Stock Option (right to buy) 10b5-1 −5,000 9,360 D
Open-market sales · 5,000 sh · avg $48.00 · $240,000
Loading xslF345X05/ownership.xml…